ALANNA EVANS-GASSES: Open Payments
NPI 1205461670 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $62 |
| Novo Nordisk Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Viatris Specialty LLC | 1 | $17 |
Products named: REXULTI, VRAYLAR, Wegovy, JARDIANCE, FANAPT, AIRSUPRA, UBRELVY, YUPELRI.
Industry payments across GA — which companies pay providers there.
